NCT03077685 2024-06-24Trial of NanoPac® in Subjects With Locally Advanced Pancreatic AdenocarcinomaNanOlogy, LLCPhase 2 Completed54 enrolled 17 charts
NCT04299880 2023-11-08Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored ProtocolsSumitomo Pharma America, Inc.Phase 1 Completed7 enrolled